BWX Technologies (BWXT), a leader in nuclear components for U.S. naval reactors and expanding into commercial nuclear applications, reports first-quarter 2026 results after market close on May 4, 2026. From what I see, this earnings release carries significant weight amid surging demand for nuclear energy solutions, driven by defense contracts and clean energy initiatives. Following a record 2025 with 18% revenue growth and Q4 non-GAAP EPS of $1.08 (beating estimates), the report will provide insight into progress toward full-year guidance. For investors, it offers a clear view of backlog conversion, margin trends, and commercial nuclear momentum—all critical factors influencing valuation in a sector set for expansion.
Wall Street anticipates first-quarter revenue of approximately $830 million, reflecting robust 20-23% year-over-year growth fueled by government operations (primarily naval nuclear propulsion) and commercial segments. EPS consensus sits at $0.92-$0.93, up slightly from $0.91 last year, with focus on non-GAAP figures excluding one-time items. Key metrics include adjusted EBITDA growth and updates to the multi-year backlog, recently at record levels.
BWXT has beaten EPS estimates in recent quarters, including Q4 2025's $1.08 versus $0.89 expected. Historically, the stock has shown mixed reactions: gains after Q3 2025 but dips post-Q4 despite beats, often tied to guidance perceptions. Investors eye confirmation of 2026 outlook amid supply chain and labor dynamics. To gauge how BWXT compares to peers, I checked it using Tickeron’s AI Screener.
Heading into earnings, sentiment is cautiously optimistic, buoyed by nuclear sector tailwinds and BWXT's strong 2025 finish. Shares have outperformed the aerospace-defense industry over the past year, reflecting backlog strength. Risks include execution on complex government contracts and commercial ramp-up delays. Post-earnings volatility could hinge on guidance alignment with consensus. One thing that stands out to me is how the stock's resilience ties directly to that record backlog.
In my research process, Tickeron’s AI Screener has become a go-to resource. This AI-powered stock and ETF discovery tool lets me filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. I customize scans by industry, market capitalization, technical indicators, price patterns, and performance metrics to pinpoint trade ideas, trending stocks, breakout candidates, and opportunities more efficiently than manual methods. It streamlines my workflow and helps uncover insights I might otherwise miss.
Following Q1 results, attention will shift to full-year 2026 guidance validation, with revenue targeted at $3.75 billion (high-teens growth) and non-GAAP EPS of $4.55-$4.70. Government Operations, representing the bulk of revenue, should benefit from naval nuclear propulsion demand, while Commercial Operations eyes nuclear fuel and microreactor progress. I’m watching this closely because commercial momentum could be a real differentiator.
Key watches include backlog evolution (recently record-high), adjusted EBITDA margins amid cost inflation, and free cash flow generation. Industry dynamics like U.S. nuclear policy support and international opportunities could provide tailwinds.
Upcoming catalysts encompass contract awards, regulatory updates for advanced reactors, and quarterly segment breakdowns. Balanced cost management will be crucial as supply chain pressures persist. In my view, this positions BWXT well if they execute effectively.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The Aroon Indicator for BWXT entered a downward trend on August 07, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 122 similar instances where the Aroon Indicator formed such a pattern. In of the 122 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWXT as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BWXT turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BWXT's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWXT advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .
BWXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BWXT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.764) is normal, around the industry mean (7.037). P/E Ratio (40.617) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.007) settles around the average of (0.017) among similar stocks. P/S Ratio (4.102) is also within normal values, averaging (20.174).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of components and services to nuclear power industry
Industry AerospaceDefense